Back
Cathay General Bancorp Vs. Novartis AG Industry Stock Comparison
Sell
50
CATY
Cathay General Bancorp
Last Price:
$42.65
Seasonality Move:
0.85%
Sell
47
NVSEF
Novartis AG
Last Price:
$107.20
Seasonality Move:
5.97%
Sell
50
Cathay General Bancorp (CATY)
is a Sell
Is Cathay General Bancorp a Buy, Sell or Hold?
-
The current Cathay General Bancorp [CATY] share price is $42.63. The Score for CATY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CATY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Novartis AG (NVSEF)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.20. The Score for NVSEF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVSEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CATY Stock Price Chart
What is Cathay General Bancorp's stock price today?
-
The Cathay General Bancorp share price today is $42.63Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATY is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing selling pressure, which indicates risk of future bearish movement.
CATY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.76 | Sell |
Relative Strength Index (14 RSI): | 37.36 | Sell |
Chaikin Money Flow: | -125877 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.99 - 45.91) | Sell |
Bollinger Bands (100): | (44.91 - 50.65) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.52 | Buy |
Relative Strength Index (14 RSI): | 45.11 | Sell |
Chaikin Money Flow: | -708751 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.53 - 115.13) | Sell |
Bollinger Bands (100): | (98.39 - 109.73) | Buy |
CATY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.55 | Sell |
20-day SMA: | 43.99 | Sell |
50-day SMA: | 45.87 | Sell |
200-day SMA: | 44.6 | Sell |
8-day EMA: | 43.45 | Sell |
20-day EMA: | 44.07 | Sell |
50-day EMA: | 45.39 | Sell |
200-day EMA: | 44.67 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.82 | Sell |
20-day SMA: | 111.72 | Sell |
50-day SMA: | 107.39 | Sell |
200-day SMA: | 107.05 | Buy |
8-day EMA: | 110.22 | Sell |
20-day EMA: | 110.51 | Sell |
50-day EMA: | 108.22 | Sell |
200-day EMA: | 105.09 | Buy |
Cathay General Bancorp Earnings Growth & CATY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.53 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cathay General Bancorp Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |